A Clinicobiological Database in Metastatic Digestive Cancers

Creation of a collection of blood samples that will be collected before and then under treatment in patients with digestive adenocarcinoma during the 1st and 2nd metastatic line and which, depending on scientific progress, can be used for research projects aimed at developing tailored patient management strategies.

Trial Details

NCT ID
NCT03978078
Phase
NA
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Biological collection
Locations (sample)
  • Montpellier, Hérault, France|43.61093,3.87635

Key Eligibility Criteria

  • Male or female ≥ 18 years old
  • Histological documentation of adenocarcinoma of the colon or rectum, small intestine, pancreas, stomach, bile duct, oesophagus
  • Patient who will receive a first or second line metastatic chemotherapy and/or targeted therapy
  • Informed consent form (ICF) signed

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →